Awakn Life Sciences Corp.
AWKNFOTCHealthcare
$0.07
+$0.00(+0.00%)
Market Cap$2708069
P/E Ratio—
52W High$0.1334
52W Low$0.04872
Awakn Life Sciences Corp.（AWKNF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · AWKNF · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2024-01 | 2023-01 | 2022-01 | 2021-01 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $0.09M | $1.50M | $0.24M | $0.00M |
| Cost of Revenue | $0.00M | $0.60M | $0.51M | $0.00M |
| Gross Profit | $0.09M | $0.89M | ($0.28M) | $0.00M |
| Gross Margin %(computed) | 100.00% | 59.64% | -117.28% | — |
| Operating Expenses | ||||
| R&D Expenses | $0.83M | $1.57M | $3.31M | $0.00M |
| G&A Expenses | $2.73M | $4.06M | $4.40M | $0.67M |
| Total Operating Expenses | $4.01M | $10.08M | $9.85M | $1.46M |
| Operating Income | ($3.93M) | ($9.19M) | ($9.79M) | ($0.84M) |
| Operating Margin %(computed) | — | -614.69% | — | — |
| Interest Income | $0.09M | $0.31M | $0.00M | $0.01M |
| Interest Expense | $0.00M | $0.00M | $0.21M | $0.00M |
| Income Before Tax | ($3.67M) | ($9.65M) | ($16.47M) | ($1.48M) |
| Income Tax Expense | $0.00M | ($0.51M) | $0.00M | $0.00M |
| Net Income | ($5.10M) | ($9.14M) | ($15.95M) | ($1.26M) |
| Net Margin %(computed) | — | -611.40% | — | — |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-0.13 | $-0.36 | $-0.73 | $-0.10 |
| Wtd Avg Shares | 29.07M | 25.20M | 21.96M | 12.63M |
| EBITDA | ($3.91M) | ($5.26M) | ($16.08M) | ($0.84M) |
| EBITDA Margin %(computed) | — | -351.98% | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · CAD · M
深入了解Awakn Life Sciences Corp.
关于Awakn Life Sciences Corp.（AWKNF）损益表
Awakn Life Sciences Corp.（AWKNF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年，AWKNF实现营收$0.00B，毛利润$0.00B（毛利率100.00%），净利润($0.01B)（净利率-5840.14%）。
常见问题
AWKNF · 4 问Awakn Life Sciences Corp.（AWKNF）2024财年营收为$0.00B，同比down94.2%。
AWKNF revenueAWKNF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09